IMS went public in 2014 and has started to buy technology companies in the healthcare sector in order to offer a comprehensive service in all the geographical areas in which it operates. In December 2015 it bought the Spanish company Iasist and in 2016 it bought a company in Canada, another in Dubai and another in the US.
About Iasist
IASIST is a company with headquarters in Barcelona and offices in Madrid, Lisbon and Chile. Leader in Benchmarking of health services in the countries where it operates. The company's value proposition is to be able to provide healthcare providers and funders with risk adjustments and own predictive values to evaluate and improve their results.
"Founded in 1989, Iasist had been owned by Axio Data since 2009, which has helped it expand in Latin America. This week we learned that Axio has received an offer for the sale of Iasist. Vidal groupanother group company, for €100m," says Diego Gutierrez, an expert in corporate finance.
About IMS HEALTH
Ims health is an American company, a world leader in information, technology and consulting services for the healthcare sector, which went public in 2014 and has acquired 4 companies in the last year.
With more than 15,000 employees in 100 countries, IMS Health has a global presence. Its more than 7,500 expert consultants connect configurable SaaS applications with the more than 10 petabytes of healthcare-specific information available on the IMS One™ cloud platform, providing unique insights into diseases, treatments, costs and health outcomes.
In 1963, it started its operations in Spain with an office in Madrid and another in Barcelona. It currently has a market production and analysis centre and an electronic data processing centre, IMS Production Hubs, both in Madrid.
Objective of the acquisition: to grow in the Spanish market.
With this purchase, IMS Health will be able to offer more services to its providers and funders in Spain, as it already does in other countries, and incorporates highly qualified professionals and experts in clinical data processing and management.
In addition, IMS Health takes a further step in its strategy to provide its clients with a more comprehensive information, consultancy and technology service, facilitating its clients' decision making by providing evidence-based results.
Other purchases made by IMS in 2016
If they are looking for investors, get in touch with us. Abra-Invest has a team of experts in alternative financing at your disposal. Call us on + 34 946424142 or fill in the form below. contact form.
Other posts that may interest you
Swedish industrial automation communication company HMS buys Spanish company Intesis Software
Promofarma receives a €2.6M round: We take a look at the online pharmacy
